Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Evidence Lacking for Endemic Chagas Disease in the United States (Response)
Suggested citation for this article
In Response: We thank Cantey et al. (1) for their work and acknowledge our shared perspective that T. cruzi is endemic in the United States, locally acquired human cases are occurring, and awareness for Chagas disease in the United States must be raised.
Norman L. Beatty, Gabriel L. Hamer, Bernardo Moreno-Peniche, Bonny Mayes, and Sarah A. Hamer
Author affiliation: University of Florida College of Medicine, Gainesville, Florida, USA (N.L. Beatty); Emerging Pathogens Institute, University of Florida, Gainesville (N.L. Beatty); Texas A&M University, College Station, Texas, USA (G.L. Hamer); University of California, Berkeley, California, USA (B. Moreno-Peniche); Texas Department of State Health Services, Austin, Texas, USA (B. Mayes); Texas A&M University College of Veterinary Medicine and Biomedical Sciences, College Station (S.A. Hamer)
References
-
Cantey PT, Hast M, Chancey RJ, Mongomery SP. Evidence Lacking for Endemic Chagas Disease in the United States. Emerg Infect Dis. 2026;32:XXX–XXX.
-
Cantey PT, Hast M, Chancey RJ, Mongomery SP. Evidence Lacking for Endemic Chagas Disease in the United States. Emerg Infect Dis. 2026;32:XXX–XXX.
Suggested citation for this article: Beatty NL, Hamer GL, Moreno-Peniche B, Mayes B, Hamer SA. Evidence Lacking for Endemic Chagas Disease in the United States. Emerg Infect Dis. 2026 May [date cited]. https://doi.org/10.3201/eid3205.260617
DOI: 10.3201/eid3205.260617
Original Publication Date: May 01, 2026
Table of Contents – Volume 32, Number 5—May 2026
file_external Top’); return p; } function AppendTopLinks() { var allChildren = $(‘#mainbody’).children(); var sections =
; for (var i = 0; i 1) $(sections).append(CreateTopLinkElement()); } AppendTopLinks(); $(document).ready(function () { $(‘#pdfPopover’).popover({ html: true, placement: ‘top’, container: $(‘#pdfPopover’).closest(‘div’), content: “This file contains the article and technical appendices, not including any Excel files.” }); $(‘#pdfPopover’).on(‘inserted.bs.popover’, function () { // CDC template js was removing close button for some reason… // so put in close button, and hook up hide on click $(‘#pdfPopover’).closest(‘div’).find(‘.popover-body’).prepend(“
Evidence Lacking for Endemic Chagas Disease in the United States (Response)
Volume 32, Number 5—May 2026
Altmetrics
Click a source for Altmetric details
What is the Altmetric Attention Score?
The Altmetric Attention Score for a research output provides an indicator of the amount of attention that it has received. The score is derived from an automated algorithm, and represents a weighted count of the amount of attention Altmetric picked up for a research output.
author.includes(‘GAIHN-HAI Team’)); authors.splice(spanIndex, 1); const lastAuthor = authors.pop().trim(); authors.push(spanElement.trim()); authors.push(‘and ‘ + lastAuthor); authorsDiv.innerHTML =authors.join(‘, ‘); } }; ]]>
Source
Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting
"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.
Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.
Our Pill Pass® Drug List is only $6.99 or less and Shipping is FREE!
